This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chia, V. M. Articles by Potter, J. D. Search for Related Content PubMed PubMed Citation Articles by Chia, V. M. Articles by Potter, J. D.

Leptin Concentrations, Leptin Receptor Polymorphisms, and Colorectal Adenoma Risk

¹ Public Health Sciences, Fred Hutchinson Cancer Research Center, ² Department of Epidemiology, University of Washington, ³ Center for Health Studies, Group Health Cooperative, Seattle, Washington and ⁴ University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin

Requests for reprints: Polly A. Newcomb, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, P. O. Box 19024, M4-B402, Seattle, WA 98109-1024. Phone: 206-667-3476; Fax: 206-667-7850. E-mail: pnewcomb{at}fhcrc.org

Obesity has been shown to be associated with an increased risk of both colorectal cancer and adenomatous polyps. One mechanism underlying this relationship may involve the growth-promoting effects of the circulating hormones associated with obesity, such as leptin. We conducted a gastroenterology clinic-based, case-control study to evaluate the relationship between circulating leptin concentrations and colorectal adenoma risk; in addition, we evaluated the relationship between leptin receptor polymorphisms and adenoma risk. Individuals with adenomas (n = 157) and colonoscopy-negative controls (n = 191), who had a clinically indicated colonoscopy, were recruited from a large health maintenance organization in the Seattle metropolitan area from 1999 to 2003. Odds ratios and 95% confidence intervals were obtained using logistic regression, adjusting for age at diagnosis, body mass index, family history of colorectal cancer, smoking history, nonsteroidal anti-inflammatory drug use, physical activity, and, among women, menopausal status and postmenopausal hormone use. Among men, those in the highest tertile of leptin concentrations had a 3.3-fold (95% confidence interval, 1.2-8.7) increased adenoma risk compared with those in the lowest tertile (P trend = 0.01). There were no associations between leptin concentrations and adenoma risk in women. There were no associations of leptin receptor genotypes or haplotypes and adenoma risk. The results of this study suggest that, in men, leptin may be associated with risk of colorectal adenomas. (Cancer Epidemiol Biomarkers Prev 2007;16(12):2697–703)